Nordea Investment Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,859
Closed -$1.41M 884
2025
Q3
$1.41M Sell
50,859
-777
-2% -$23.9K ﹤0.01% 787
2025
Q2
$1.58M Buy
51,636
+30
+0.1% +$852 ﹤0.01% 765
2025
Q1
$1.43M Buy
51,606
+1,156
+2% +$36.6K ﹤0.01% 755
2024
Q4
$1.81M Buy
50,450
+2,723
+6% +$102K ﹤0.01% 700
2024
Q3
$1.8M Sell
47,727
-2,742
-5% -$113K ﹤0.01% 710
2024
Q2
$2.3M Sell
50,469
-9,028
-15% -$415K ﹤0.01% 678
2024
Q1
$2.9M Sell
59,497
-595
-1% -$29.1K ﹤0.01% 649
2023
Q4
$3.23M Sell
60,092
-2,188
-4% -$111K ﹤0.01% 627
2023
Q3
$3.65M Sell
62,280
-832
-1% -$52K 0.01% 573
2023
Q2
$3.97M Sell
63,112
-7,558
-11% -$481K 0.01% 565
2023
Q1
$4.45M Sell
70,670
-77
-0.1% -$4.59K 0.01% 543
2022
Q4
$3.77M Sell
70,747
-4,300
-6% -$233K 0.01% 574
2022
Q3
$4.25M Sell
75,047
-815
-1% -$53.9K 0.01% 551
2022
Q2
$5.46M Sell
75,862
-3,744
-5% -$279K 0.01% 510
2022
Q1
$6.34M Buy
79,606
+1,399
+2% +$126K 0.01% 538
2021
Q4
$7.93M Sell
78,207
-582
-0.7% -$58.1K 0.01% 472
2021
Q3
$7.22M Sell
78,789
-938
-1% -$90.2K 0.01% 510
2021
Q2
$8.17M Buy
79,727
+7,458
+10% +$749K 0.01% 457
2021
Q1
$7.08M Sell
72,269
-2,141
-3% -$195K 0.01% 461
2020
Q4
$5.74M Buy
74,410
+15,212
+26% +$1.18M 0.01% 525
2020
Q3
$4.34M Sell
59,198
-57,632
-49% -$4.62M 0.01% 525
2020
Q2
$8.34M Sell
116,830
-20,780
-15% -$1.63M 0.01% 523
2020
Q1
$8.03M Sell
137,610
-16,561
-11% -$1.15M 0.02% 341
2019
Q4
$12.2M Sell
154,171
-299
-0.2% -$22K 0.02% 320
2019
Q3
$10.7M Buy
154,470
+76,914
+99% +$5.16M 0.02% 330
2019
Q2
$6.16M Buy
77,556
+18,543
+31% +$1.47M 0.01% 398
2019
Q1
$4.95M Sell
59,013
-3,302
-5% -$345K 0.01% 577
2018
Q4
$7.34M Buy
62,315
+34,500
+124% +$3.99M 0.02% 424
2018
Q3
$3.35M Sell
27,815
-220,448
-89% -$27.4M 0.01% 789
2018
Q2
$28.6M Sell
248,263
-106,338
-30% -$11.6M 0.07% 197
2018
Q1
$30.5M Buy
354,601
+10,458
+3% +$810K 0.07% 173
2017
Q4
$25.5M Sell
344,143
-74
-0% -$4.95K 0.06% 188
2017
Q3
$19.9M Buy
344,217
+8,768
+3% +$518K 0.05% 213
2017
Q2
$21.5M Buy
335,449
+16,307
+5% +$1M 0.05% 194
2017
Q1
$18.4M Buy
319,142
+15,294
+5% +$913K 0.05% 206
2016
Q4
$18.6M Buy
303,848
+3,946
+1% +$257K 0.05% 214
2016
Q3
$20.7M Buy
299,902
+289,718
+2,845% +$19.1M 0.05% 194
2016
Q2
$567K Buy
+10,184
New +$614K ﹤0.01% 733

Other funds holding USNA

Nordea Investment Management's USNA Position: Q4 2025 in Review

Nordea Investment Management sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 50,859 shares — an estimated $1.41M sold.

Nordea Investment Management first reported a position in USNA in Q2 2016 and held it in 38 quarters. The position peaked at $30.5M in Q1 2018. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

  • Nordea Investment Management reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
  • Nordea Investment Management sold 50,859 Usana Health Sciences shares in Q4 2025, an estimated $1.41M.
  • Nordea Investment Management first reported a position in Usana Health Sciences in Q2 2016 and held it in 38 quarters.
  • Nordea Investment Management's Usana Health Sciences position peaked at $30.5M in Q1 2018.
  • 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Nordea Investment Management's 13F filing for Q4 2025, filed 8 Jan 2026.